Drug
Erythropoietin clinical trials
Keep track of what changes. Save the Erythropoietin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
95 studies that test it; most in 2006 (7)
| Year | Studies |
|---|---|
| 1997 | 2 |
| 1998 | 1 |
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 7 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 7 |
| 2018 | 3 |
| 2019 | 6 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 89
Yonsei University (3) · University of California, San Francisco (3) · University of Zurich (3) · Northwestern University (2) · Seoul National University Hospital (2) · University of Copenhagen (2) · Zhengzhou University (2) · Ajou University School of Medicine (2)
Often tested with
Tested in the same studies.
Epoetin Alfa (5) · Iron sucrose (2) · Filgrastim (2) · Ferric carboxymaltose (2) · Iron-Dextran Complex (1) · GSK1278863 (1) · Cord blood (1) · Irbesartan (1)
Studies
Open first, then newest update. How each study uses Erythropoietin is read from its arms, and is right about nine times in ten.
Testing it · 97
- Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.Not yet recruitingPhase 3Badr UniversityNCT07296146Written as Erythropoietin + Probiotic
- Erythropoietin in HIE NeonateNot yet recruitingEarly Phase 1Assiut UniversityNCT06590155Written as Erythropoietin
- Xenograft with or Without Erythropoietin in Immediate Dental ImplantNot yet recruitingNot applicableCairo UniversityNCT06601400Written as Erythropoietin (EPO) with xenograft
- PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)RecruitingPhase 2Federal University of São PauloNCT06542393Written as Erythropoietin
- Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)RecruitingPhase 3Imperial College LondonNCT05395195Written as Erythropoietin
- Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in ChildrensNot yet recruitingPhase 3Blau Farmaceutica S.A.NCT05704894Written as Erythropoietin
- Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy VolunteersCompletedNot applicableRennes University HospitalNCT00687518Written as Erythropoietin
- Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on DialysisCompletedPhase 3American Regent, Inc.NCT00236964Written as Iron Sucrose + Erythropoietin
- Practical Anemia Bundle for SusTained Blood RecoveryCompletedPhase 2Mayo ClinicNCT05167734Written as Erythropoietin (EPO)
- Pharmacological Countermeasures for High AltitudeActive, not recruitingPhase 4United States Army Research Institute of Environmental MedicineNCT05300477Written as Erythropoietin
- Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)CompletedPhase 2GlaxoSmithKlineNCT03457701Written as rhEPO
- Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant RecipientsActive, not recruitingPhase 4Northwestern UniversityNCT05325073Written as Erythropoietin
- Traumatic Optic Neuropathy Treatment Trial 2CompletedPhase 3Iran University of Medical SciencesNCT03308448Written as Recombinant human erythropoietin
- Topical Erythropoietin Hydrogel in Management of Oral Lichen PlanusStatus unknownPhase 3Ain Shams UniversityNCT06135259Written as erythropoietin
- EPO for Postop Delirium in Elderly PatientsCompletedPhase 4Yonsei UniversityNCT06178835Written as Erythropoietin
- Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya PatientsActive, not recruitingNot applicableSeoul National University HospitalNCT03882060Written as erythropoietin
- Effects of Erythropoietin for Cognitive Side-effects of ECTCompletedPhase 2Martin Balslev JørgensenNCT03339596Written as Erythropoietin
- Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic SyndromesCompletedPhase 3Eastern Cooperative Oncology GroupNCT00003138Written as Erythropoietin
- Tracing Changed Production of Red Blood CellsCompletedNot applicableUniversity of CopenhagenNCT05833477Written as Recombinant human erythropoietin
- Effects of Erythropoietin on Cognition and Neural Activity in Mood DisordersCompletedPhase 2Lars Vedel KessingNCT03315897Written as Erythropoietin
See all 97 studies that test Erythropoietin →
Given in every arm · 6 — Erythropoietin is usual care beside what is tested
- Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCTNot yet recruitingPhase 3The First Affiliated Hospital of Soochow UniversityNCT05669079Written as Recombinant human erythropoietin
- Decitabine for Poor Graft Function Post Allo-HSCTCompletedPhase 3The First Affiliated Hospital of Soochow UniversityNCT05907499Written as Recombinant human erythropoietin
- The Effectiveness of Lactoferrin in the Management of Treatment-induced AnemiaStatus unknownPhase 1Cyprus University of TechnologyNCT03683810Written as Recombinant human erythropoietin
- Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency AnemiaCompletedNot applicableJinling Hospital, ChinaNCT01823029Written as erythropoietin
- A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic SyndromesCompletedPhase 1/2Celgene CorporationNCT00910858Written as Recombinant human erythropoietin
- A Safety Study of Pentoxifylline for the Treatment of AnemiaTerminatedPhase 2Fresenius Medical Care North AmericaNCT01102218Written as Erythropoietin
As the comparator · 16 — what is tested is compared with Erythropoietin
- Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological MalignanciesNot yet recruitingPhase 2/3Nanfang Hospital, Southern Medical UniversityNCT07636486Written as Epoetin
- Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis PatientsNot yet recruitingPhase 4Tianjin Medical University General HospitalNCT07162090Written as Recombinant human erythropoietin (EPO)
- Roxadustat Versus Erythropoietin for Anaemia Treatment in Diabetic NephropathyCompletedNot applicableHanzla ArshadNCT07786168Written as Erythropoietin
- A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)CompletedPhase 4AstraZenecaNCT04655027Written as rHuEPO
- Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)CompletedPhase 3GlaxoSmithKlineNCT02879305Written as rhEPO
- Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney DiseaseCompletedPhase 4Rufaida MazahirNCT04959578Written as Recombinant human erythropoietin
- A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)CompletedPhase 2GlaxoSmithKlineNCT01977573Written as rhEPO
- Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated AnemiaCompletedPhase 2GlaxoSmithKlineNCT01977482Written as rhEPO
- 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney DiseaseCompletedPhase 2GlaxoSmithKlineNCT01587924Written as rhEPO
- A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis PatientsCompletedPhase 3Hoffmann-La RocheNCT00077610Written as Epoetin alfa or beta
- A Study of Mircera for the Treatment of Anemia in Dialysis PatientsCompletedPhase 3Hoffmann-La RocheNCT00077597Written as epoetin
- A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.CompletedPhase 3Hoffmann-La RocheNCT00546481Written as Epoetin
- NESP Pediatric StudyCompletedPhase 3AmgenNCT00527137Written as rHuEPO
- Clinical Study of R744 to Hemodialysis PatientsCompletedPhase 3Chugai PharmaceuticalNCT00491868Written as rHuEPO
- Anemia in Patients With a Non-Myeloid MalignancyCompletedPhase 3AmgenNCT00038064Written as rHuEPO
- Treatment for Patients With Non-Myeloid Malignancies Receiving ChemotherapyCompletedPhase 3AmgenNCT00111137Written as rHuEPO